Israel Englander Athenex, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.12 - $0.21 $281,558 - $492,728	2,346,324 Added 56.27%	6,516,142 $961,000
Q3 2022 Nov 14, 2022	SELL	$0.24 - $1.11 $98,010 - $453,298	-408,377 Reduced 8.92%	4,169,818 $1.12 Million
Q2 2022 Aug 15, 2022	BUY	$0.41 - $0.91 $957,442 - $2.13 Million	2,335,225 Added 104.11%	4,578,195 $1.87 Million
Q1 2022 May 16, 2022	SELL	$0.79 - $1.59 $757,438 - $1.52 Million	-958,783 Reduced 29.95%	2,242,970 $1.86 Million
Q4 2021 Feb 14, 2022	BUY	$1.36 - $2.94 $1.46 Million - $3.15 Million	1,070,063 Added 50.2%	3,201,753 $4.35 Million
Q3 2021 Nov 15, 2021	BUY	$2.97 - $4.84 $1.4 Million - $2.28 Million	471,361 Added 28.39%	2,131,690 $6.42 Million
Q2 2021 Aug 16, 2021	BUY	$3.71 - $5.13 $2.36 Million - $3.27 Million	636,805 Added 62.22%	1,660,329 $7.67 Million
Q1 2021 May 17, 2021	BUY	$4.08 - $14.75 $1.25 Million - $4.52 Million	306,177 Added 42.68%	1,023,524 $4.4 Million
Q4 2020 Feb 16, 2021	BUY	$11.06 - $14.01 $1.29 Million - $1.64 Million	116,856 Added 19.46%	717,347 $7.93 Million
Q3 2020 Nov 16, 2020	BUY	$10.26 - $14.55 $3.18 Million - $4.51 Million	309,816 Added 106.59%	600,491 $7.27 Million
Q2 2020 Aug 14, 2020	BUY	$7.11 - $13.76 $1.96 Million - $3.79 Million	275,386 Added 1801.2%	290,675 $4 Million
Q1 2020 May 14, 2020	SELL	$5.71 - $15.85 $4.39 Million - $12.2 Million	-768,292 Reduced 98.05%	15,289 $118,000
Q4 2019 Feb 14, 2020	SELL	$9.6 - $17.75 $2.61 Million - $4.82 Million	-271,768 Reduced 25.75%	783,581 $12 Million
Q3 2019 Nov 14, 2019	BUY	$12.16 - $21.0 $7.41 Million - $12.8 Million	609,644 Added 136.78%	1,055,349 $12.8 Million
Q2 2019 Aug 15, 2019	SELL	$9.44 - $19.8 $1.47 Million - $3.09 Million	-155,990 Reduced 25.93%	445,705 $8.83 Million
Q2 2019 Aug 14, 2019	BUY	$9.44 - $19.8 $5.68 Million - $11.9 Million	601,695 New	601,695 $62.4 Million
Q3 2018 Nov 14, 2018	SELL	$15.53 - $19.97 $403,811 - $519,259	-26,002 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$15.88 - $19.5 $1.71 Million - $2.1 Million	-107,661 Reduced 80.55%	26,002 $485,000
Q1 2018 May 15, 2018	BUY	$13.53 - $17.47 $942,513 - $1.22 Million	69,661 Added 108.84%	133,663 $2.27 Million
Q4 2017 Feb 14, 2018	BUY	$14.41 - $19.15 $580,751 - $771,783	40,302 Added 170.05%	64,002 $1.02 Million
Q3 2017 Nov 14, 2017	BUY	$13.5 - $19.51 $319,950 - $462,387	23,700	23,700 $415,000

Others Institutions Holding ATNX

# of Institutions

Shares Held

1.46M

Call Options Held

Put Options Held

Empery Asset Management, LP New York, NY

1.45M
Shares

$14,521
2.33% of portfolio
Eaton Vance Management Boston, MA

12K
Shares

$120
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Athenex, Inc.

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

More about ATNX

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account